Dr. Mark Jacob Sorensen, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 75 Claremont St, Suite B, Kalispell, MT 59901 Phone: 406-752-2277 Fax: 406-752-5029 |
Wallace S Wilder, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 210 Sunnyview Ln, Suite 103, Kalispell, MT 59901 Phone: 406-752-8300 Fax: 406-752-3542 |
Dr. Nathan Christian Bingham, M.D., PHD. Pediatrics Medicare: Medicare Enrolled Practice Location: 202 Conway Dr, Kalispell, MT 59901 Phone: 406-758-7490 |
Daniel Lustig, MD Pediatrics - Pediatric Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 202 Conway Dr Ste 200, Kalispell, MT 59901 Phone: 844-215-7969 Fax: 406-758-7080 |
Paul Michael Berkram, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-5310 |
Austine Kuder Siomos, M.D. Pediatrics - Pediatric Cardiology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-257-8996 |
Jennifer Laura Shipley, PNP Pediatrics Medicare: Medicare Enrolled Practice Location: 1995 Four Mile Dr, Kalispell, MT 59901 Phone: 406-261-1847 |
Rachel Christine Brennan, MD Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 202 Conway Dr Ste 200, Kalispell, MT 59901 Phone: 406-758-7490 Fax: 406-758-7080 |
Mark Kaneta, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-5391 Fax: 406-751-2988 |
News Archive
The U.S. Food and Drug Administration issued four warning letters to companies that manufacture and market over-the-counter (OTC) drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria (MRSA).
HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Quorum Health Resources (QHR), the nation's largest hospital management company and one of the top 10 healthcare consulting firms in the United States, announced today a partnership that enables both HealthStream and QHR to deliver a wider range of best-in-class solutions to the hospital market.
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.
The SARS-CoV-2 virus has been shown to infect a wide range of animals naturally and experimentally, and prior studies indicate deer are susceptible to infection. White-tailed deer (Odocoileus virginianus) fawns have been found to be susceptible to SARS-CoV-2.
A protein isolated from beneficial bacteria found in yogurt and dairy products could offer a new, oral therapeutic option for inflammatory bowel disorders, suggests a study led by Vanderbilt University Medical Center researcher Fang Yan, M.D., Ph.D.
› Verified 2 days ago